Patient Experiences with Pharmacogenetic Testing in a Primary Care Setting
Authors:
- 20 September 2016
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 17 (15) , 1629-1636
Abstract
Aim: To investigate patient experiences with pharmacogenetic (PGx) testing. Methods: Patients were offered PGx testing through a study on pharmacist-assisted delivery of PGx testing and invited to complete pre- and post-testing surveys about their experience. Results: Of 63 patients tested, 17 completed the baseline survey (27%). Interest in testing was mostly impacted by desire to inform selection of best treatment (n = 13). Seven of 12 patients that completed the follow-up survey indicated that their provider discussed the test result with them. Five patients understood their test result very or somewhat well. All would be likely to have PGx testing again. Conclusion: Patients perceived PGx testing to be useful, though more effort may be needed to improve patient–provider communication of test results.Keywords
Funding Information
- National Institute of Health (RO1GM081416)
- Inova Translational Medicine Institute
This publication has 34 references indexed in Scilit:
- Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trialThe Pharmacogenomics Journal, 2013
- Public Perspectives About Pharmacogenetic Testing and Managing Ancillary FindingsGenetic Testing and Molecular Biomarkers, 2012
- Survey of US public attitudes toward pharmacogenetic testingThe Pharmacogenomics Journal, 2011
- Sharing Genetic Test Results in Lynch Syndrome: Communication With Close and Distant RelativesClinical Gastroenterology and Hepatology, 2008
- Pharmacogenetics and the concept of individualized medicineThe Pharmacogenomics Journal, 2005
- A lay prescription for tailor-made drugs—focus group reflections on pharmacogenomicsHealth Policy, 2005
- Communication of BRCA1 and BRCA2 results to at‐risk relatives: A cancer risk assessment program's experienceAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2003
- A brief assessment of concerns associated with genetic testing for cancer: The multidimensional impact of cancer risk assessment (MICRA) questionnaire.Health Psychology, 2002
- A brief assessment of concerns associated with genetic testing for cancer: The multidimensional impact of cancer risk assessment (MICRA) questionnaire.Health Psychology, 2002
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986